Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent Manner

Overview of attention for article published in Clinical Cancer Research, June 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 1 news outlet
twitter: 10 X users

patent: 2 patents
f1000: 1 research highlight platform

Readers on

mendeley: 46 Mendeley

So far, Altmetric has seen 11 X posts from 10 X users, with an upper bound of 34,282 followers.

Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent Manner https://t.co/8b0t39v8fQ

RT @saxotomy: Interesting demonstration of another potential use of #trabectedin in transl-associated #sarcoma; and also interactions with…

RT @pharma_jonpi: Yondelis Combinado con Irinotecan para el Tratamiento de Ewing Sarcoma . Datos obtenidos proporcionan la Justificación pa…

Yondelis Combinado con Irinotecan para el Tratamiento de Ewing Sarcoma . Datos obtenidos proporcionan la Justificación para Evaluar dicha Combinación en la Clínica . https://t.co/iy6LGAEXMe #pharmamar https://t.co/2NQqlT9GmQ

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.